Αρχική World News Hamlet Drug, Modeled After Protein In Breast Milk, Kills Tumor Cells While...

Hamlet Drug, Modeled After Protein In Breast Milk, Kills Tumor Cells While Leaving Healthy Ones Unharmed

For nearly 30 years, researchers have been testing an experimental drug called Hamlet on different cancers in both animals and humans.It was created as a replica of a protein found in human breast milk.A man-made version of alpha-lactalbumin — which is the most common protein found in human breast milk — Hamlet stands for Human Alpha-lactalbumin Made Lethal to Tumor cells. When the protein binds to oleic acid, a fatty acid that is thought to be anti-inflammatory, it can destroy cancer cells.It’s currently undergoing clinical trials in humans, and researchers have found that the drug can kill tumors cells while leaving healthy cells unscathed.At this point, it has been shown to kill 40 different types of cancer.OriginsPhoto: Adobe Stock/petunyia
Hamlet was created because of a happy accident. In 1995, at Lund University, Sweden, Professor Catharina Svanborg and her postgraduate student, Anders Håkansson, launched an experiment to figure out how breast milk was able to fight off germs and be considered antimicrobial.Human cancer cells are often used in scientific studies, whether or not the studies are focusing on cancer. This is because cancer cells can live on indefinitely, and since they are human cells, they provide a great opportunity for experimentation.The experiment didn’t go as planned, however, because the cancer cells began disappearing.After deeper analysis, Svanborg concluded that the breast milk was actually causing the cancer cells to undergo apoptosis — AKA, “commit suicide.”“Looking down the microscope at the dying tumor cells, we were quite excited, especially when the experiment was repeated and showed the same effect twice. We had used non-cancerous cells for a long time in similar experiments and they had not died,” Svanborg said.However, people in the medical community were skeptical and didn’t take the work seriously at first.
Additional TrialsPhoto: Adobe Stock/motortionSo Svanborg and her team have spent the last 30 years or so running experiment after experiment. Over this time, Hamlet has killed over 40 different types of cancer cells in multiple trials.In studies involving mice, Hamlet stunted the growth of brain and bladder tumors. In one study, baby mice were given Hamlet in their drinking water and didn’t develop colon cancer like they should have, indicating that Hamlet could be used in people with a genetic susceptibility to cancer.Then a trial on nine bladder cancer patients proved that Hamlet’s magic could work on humans as well. Eight of the nine patients passed tumors cells out of their body through their urine two hours after after they were given Hamlet. Their tumors shrank or changed character, and healthy surrounding tissue was not negatively affected.
Current TrialPhoto Credit: Adobe Stock/ninunThe current study is the largest trial of Hamlet to date, and involves 40 bladder cancer patients. It’s taking place in Prague, Czech Republic. Bladder cancer has a high recurrence rate and causes 200,000 deaths a year worldwide.Hamlet is given via a catheter into the bladder, with each patient getting six separate doses over a period of one month before undergoing surgery.Preliminary results should be available later in 2019, but the 40 patients will be monitored for two years so researchers can observe the long-term effects of the drug after treatment has ended.
Photo: Adobe Stock/Kateryna_KonHamlet is able to effectively kill cancer cells without harming healthy tissue — meaning little or no side effects, unlike chemotherapy and radiation.“We believe the treatment points to new ways of reaching a balance between therapeutic efficacy and side effects,” Svanborg said.The team is continuing to look at other cancers too, not just bladder cancer. Their ultimate goal to to use Hamlet as a preventative measure.
“If efficacy can be combined with a lack of toxicity, it is possible that this treatment can be used both as prevention and therapy. The vision would be to make it available worldwide, to patients who are susceptible to certain cancers, or who suffer from tumours that can be reached and treated with this substance,” Svanborg said.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

Mother Spent 14 Weeks Battling Breast Cancer Alone During COVID-19 Lockdown

Battling cancer is difficult for anyone, but it’s even harder when you have to do it alone. That’s what happened to Samantha Currie. Samantha, 27,...

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...

Nivolumab Improves Survival for Some Patients with Advanced Stomach Cancer

October 20, 2020, by NCI Staff Some people with advanced stomach cancers may live longer if they are initially treated with nivolumab (Opdivo) and chemotherapy. Credit: National Cancer Institute Some...

Sugar and cancer – what you need to know

This post was first published in 2017 but has been reviewed and updated in October 2020. There’s a lot of confusing information and advice out...

FDA Extends Approval of Pembrolizumab for Classical Hodgkin Lymphoma

On 14 October 2020, the US Food and Drug Administration (FDA) extended the approval of pembrolizumab (KEYTRUDA®, Merck Sharp & Dohme Corp.) for the...